-
ENDRA Life Sciences and Rocky Vista University College of Osteopathic Medicine Partnering for Clinical Study of Thermo Acoustic Enhanced Ultrasound Device
Jul 1, 2019
ANN ARBOR, MI / ACCESSWIRE / July 1, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, today announced that it is partnering with Rocky Vista U...read more > -
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019)
Jun 24, 2019
Newly Appointed Chief Commercial Officer (CCO) Renaud Maloberti to Showcase ENDRA's Breakthrough Thermo Acoustic Enhanced UltraSound (TAEUS) Technology Addressing Fatty Liver Disease...read more > -
ENDRA Life Sciences Appoints Renaud Maloberti as Chief Commercial Officer
Jun 3, 2019
20-Year Global Commercial Medical Imaging Veteran to Lead Rollout of ENDRA Technology in European and U.S. Markets...read more > -
ENDRA Life Sciences Reports First Quarter 2019 Financial & Operational Results
May 14, 2019
Management to Host First Quarter 2019 Conference Call Today at 4:30 p.m. ET...read more > -
ENDRA Life Sciences to Host First Quarter 2019 Results Conference Call on Tuesday, May 14, 2019 at 4:30 p.m. ET
Apr 24, 2019
ANN ARBOR, MI / ACCESSWIRE / April 24, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, will hold a conference call on Tuesday, May 14, 201...read more > -
ENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of Tissue
Apr 17, 2019
Newly Issued Patent Strengthens Accuracy of TAEUS Fat Quantification Methodologies ...read more > -
ENDRA Life Sciences Receives ISO 13485 Certification
Apr 3, 2019
ANN ARBOR, MI / ACCESSWIRE / April 3, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, has received Medical Device Quality Management Syste...read more > -
ENDRA Life Sciences Reports Initial Findings on First Human TAEUS Feasibility Study of Liver Fat
Mar 29, 2019
ANN ARBOR, MI / ACCESSWIRE / March 29, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, has reported initial findings on the first human The...read more > -
ENDRA Life Sciences Reports Full Year 2018 Financial & Operational Results
Mar 11, 2019
Management to Host Full Year 2018 Conference Call Today at 4:30 p.m. ET ...read more > -
ENDRA Life Sciences to Host Fourth Quarter and Full Year 2018 Results Conference Call on Monday, March 11, 2019 at 4:30 p.m. ET
Feb 22, 2019
ANN ARBOR, MICHIGAN / ACCESSWIRE / February 22, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, will hold a conference call on Monday, Marc...read more >
